Complement component 7
Complement Component 7 (C7) is a protein that plays a crucial role in the immune system, specifically in the complement system, which is a part of the innate immune response. C7 is involved in the formation of the Membrane Attack Complex (MAC), a structure that creates pores in the membranes of target cells, leading to their lysis and death. This process is essential for the defense against pathogens such as bacteria and viruses.
Structure and Function[edit]
C7 is a glycoprotein composed of several domains that allow it to interact with other components of the complement system. Its activation and function are tightly regulated to prevent damage to host cells. Upon activation, C7 binds to the C5bC6 complex on the surface of the target cell. This binding is a critical step in the assembly of the MAC, as it allows the recruitment of C8 and multiple C9 molecules, leading to the formation of the pore.
Genetics[edit]
The gene encoding C7 is located on human chromosome 5. Mutations in this gene can lead to deficiencies in the complement system, which may result in increased susceptibility to infections and possibly autoimmune diseases.
Clinical Significance[edit]
Deficiencies in C7 can lead to a condition known as complement deficiency, which is characterized by an increased susceptibility to bacterial infections, particularly Neisseria meningitidis, which can cause meningitis and sepsis. Diagnosis of C7 deficiency involves measuring the levels of complement proteins in the blood and assessing the functional activity of the complement system.
Treatment for complement deficiencies may include antibiotics to prevent infections and, in some cases, complement protein replacement therapy. Research is ongoing to develop more targeted therapies for complement-related diseases.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian